We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Ultrasound Probe, Sterile Procedure Kit Designed for Needle-Guided Procedures

By HospiMedica International staff writers
Posted on 03 Apr 2012
An ultrasound probe and sterile procedure kit provides needle-guided procedures with a precise path to the anatomic target and uninterrupted needle visualization throughout an entire procedure.

Soma Access Systems, LLC (Greenville, SC, USA) has received 510(k) clearance from the US Food and Drug Administration (FDA) for its AxoTrack sterile procedure kit. More...
This is combined with the recent news that Terason (Burlington, MA, USA), a manufacturer of high-performance portable ultrasound systems, received 510(k) clearance for the first ultrasound probe to be equipped with Soma’s patented AxoTrack virtual needle technology.

Together, the Terason ultrasound system AxoTrack-equipped probe and AxoTrack sterile procedure kit comprise a system specifically designed to perform needle-guided procedures accurately and effectively every time. When tested in vitro, the first attempt success rate for accurate needle placement using AxoTrack technology was 99.3% versus 37.1% with the standard freehand method.

“This device has the potential to increase physician accuracy and set a new standard of care, significantly reducing morbidity and mortality. The AxoTrack system successfully combines life-saving precision with user-friendly functionality,” said Stephen F. Ridley, MD, president and chief medical officer of Soma Access Systems, LLC.

AxoTrack will be available on Terason ultrasound systems by mid-Summer 2012. Additional ultrasound manufacturers are expected to launch AxoTrack platforms in the near future. Introduced as ExactTrack during beta testing, the AxoTrack system is the first product in a comprehensive range of solutions from Soma Access Systems that will carry the AxoTrack brand.

Terason, a division of Teratech Corp., is a diagnostic ultrasound technology company that develops compact equipment to generate diagnostic images previously possible only using large, expensive machines. A developer of portable ultrasound systems, Terason was established by Dr. Alice Chiang in 1994 as a spin-off of Massachusetts Institute of Technology (MIT) Lincoln Laboratory (Cambridge, MA, USA).

Related Links:

Soma Access Systems
Terason



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.